The Akufo-Addo-Bawumia administration, along with key figures such as Finance Minister Ken Ofori-Atta, has been marred by numerous allegations of corruption, mismanagement, and profligate spending .

"Most scorpions are likely capable of spraying venom. They just don't do it. This extreme behavioral response is only known ...

On Windows 11, desktop elements like the Taskbar, Start menu, and certain apps, such as the Settings app, use a new transparent base layer featuring the Mica material from the Microsoft Fluent ...

Bengaluru: Heads Up For Tails (HUFT) has started talks to raise $40 million from new and existing investors, three people familiar with the matter told Mint, underscoring the growth potential of t ...

In an era where information flows instantly, and workplace dynamics constantly shift, the question isn't whether to be transparent—it's how to make transparency a competitive advantage in the ...

An investigation is under way following the recent shooting dead of a white-tailed eagle in Co Westmeath. The National Parks and Wildlife Service (NPWS) is appealing for information, following the ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.